The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
ZIVO · Healthcare · Shallow moat
Doesn't clear the bar
The returnsOnCapital component abstained: Not enough years of ROIC data to score returns on capital. The other four 20% weights were renormalized over the scored 80%.
LFST · Healthcare · Shallow moat
Doesn't clear the bar
The pricingPower component abstained: Not enough years of gross-margin data to score pricing power. The other four 20% weights were renormalized over the scored 80%.
TEVA · Healthcare · Shallow moat
Doesn't clear the bar
| Measure | ZIVO | LFST | TEVA | BCRX |
|---|---|---|---|---|
| Moat Score (0–100) | 53 (highest) | 53 (highest) | 53 (highest) | 53 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 70 | 85 (highest) | 69 | 80 |
| Pricing power | 44 | — | 79 | 100 (highest) |
| Returns on capital | — | 0 | 7 (highest) | 0 |
| Balance-sheet safety | 55 | 49 | 56 | 61 (highest) |
| Capital allocation | 44 | 80 (highest) | 55 | 24 |
| No price data | No price data | 4589% above value if growth stopped today | No price data | |
| Market cap | $18.1M | $4.2B | $35.4B | $2.0B |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2024 | FY2025 | FY2025 | FY2025 |